The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome
Open accessAbstract
Objective Evaluation of clinical and endocrine effects of naltrexone administration in obese women with PCOS. Design Open, controlled, clinical study. Setting Department of Reproductive Medicine and Child Development, Section of Gynecology and Obstetrics, University of Pisa, Pisa, Italy. Patient(s) Ten PCOS women were studied. Intervention(s) Women were treated with naltrexone (50 mg/day) for 6 months. Main outcome measure(s) Body mass index and the menstrual cyclicity during naltrexone treatment were assessed. Basal levels of LH, FSH, 17beta-estradiol (E(2)), 17-hydroxyprogesterone, total and free T, androstenedione, dehydroepiandrosterone sulfate, cortisol, sex hormone-binding globulin were evaluated before treatment and every 3 months. Progesterone levels were measured in the luteal phase during the sixth month. Gonadotropin response to GnRH administration (10 microg) and a 75-g oral glucose tolerance test were performed before and every 3 months. Result(s) Body mass index significantly decreased from 29.94 +/- 1.04 to 26.07 +/- 0.81 during treatment. The menstrual cyclicity improved in 80% of PCOS women: the mean cycle length was 40-360 days before treatment and ranged between 25 and 120 days and 28-120 days after 3 and 6 months of treatment. Plasma levels of free T, androstenedione, dehydroepiandrosterone sulfate, and cortisol significantly decreased. Fasting glucose-to-insulin ratio improved in women with insulin resistance. Conclusion(s) Naltrexone may have a beneficia…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Although some studies have been inconclusive,75,76 the opioid antagonist naltrexone is effective in reducing endocrine symptoms in women with PCOS,77–79 also suggesting that high β-endorphin levels are a feature of this condition.”
From Prenatal Origins of Endometriosis Pathology and Pain: Reviewing the Evidence of a Role for Low Testosterone (2023) · cites this paper as [77]
Citations
Cites
Franks, S. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509283331307 · Cited by 2,463
Franks, S. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.1.89 · Cited by 806
Legro, R. S., Finegood, D., & Dunaif, A. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.8.5054 · Cited by 673 · cited 2×
“We evaluated the fasting G:I ratio that was proposed (20) as a useful test for identifying women with PCOS with insulin resistance.”
BackgroundMethodClark, A. M., Ledger, W., Galletly, C., Tomlinson, L., Blaney, F., Wang, X., & Norman, R. J. (1995) · Human Reproduction · doi:10.1093/oxfordjournals.humrep.a135772 · Cited by 642 · cited 1×
“(30) found that 12 of 13 subjects who had lost weight during F I G U R E 3”
BackgroundPOLYCYSTIC OVARY SYNDROME: A CHANGING PERSPECTIVE
FRANKS, S. (1989) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1989.tb00457.x · Cited by 526 · cited 1×
“Obesity is frequently found in women with PCOS with a range of 30%–60% (13).”
BackgroundWALDSTREICHER, J., SANTORO, N. F., HALL, J. E., FILICORI, M., & CROWLEY, W. F. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-66-1-165 · Cited by 407 · cited 1×
“An augmented GnRH pulse frequency and an increased sensitivity of the pituitary to GnRH account for the abnormal gonadotropin levels (2).”
BackgroundTHE ROLE OF ENDOGENOUS OPIATES ON LH SECRETION DURING THE MENSTRUAL CYCLE
Quigley, M. E., & Yen, S. S. C. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-1-179 · Cited by 355
NESTLER, J. E., BARLASCINI, C. O., MATT, D. W., STEINGOLD, K. A., PLYMATE, S. R., CLORE, J. N., & BLACKARD, W. G. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-6-1027 · Cited by 338 · cited 1×
“, diazoxide, octreotide, or weight loss) does not always change the circulating levels of DHEAS and A (34, 35).”
BackgroundWallach, E. E., & Goldzieher, J. W. (1981) · Fertility and Sterility · doi:10.1016/s0015-0282(16)45429-4 · Cited by 296
β-ENDORPHIN IN THE HUMAN PANCREAS
BRUNI, J. F., WATKINS, W. B., & YEN, S. S. C. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-4-649 · Cited by 198 · cited 1×
“endocrine pancreas (9) and the findings that endorphins stimulate insulin and glucagon secretion in vivo (10) suggest a possible role for endogenous opiates in glycoregulation.”
Background
Research works printed but not linked: 2
- Lanzone, 1995, Evidence of a distinct derangement of opioid tone in hyperinsulinemic patients with polycystic ovarian syndrome, J Clin Endocrinol Metab, 80, 3501
- Cozzolino, 1996, The involvementof the opioid system in human obesity, J Clin Endocrinol Metab, 81, 713
Cited by
Elman, I., Borsook, D., & Lukas, S. E. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301051 · Cited by 169
Polycystic Ovary Syndrome: Effect and Mechanisms of Acupuncture for Ovulation Induction
Johansson, J., & Stener‐Victorin, E. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/762615 · Cited by 149
“That naltrexone, a μ-receptor that antagonist induces ovulation and decreases LH concentration, indicates also a role of β-endorphin in PCOS [143–145].”
BackgroundImpact of the opioid system on the reproductive axis
Böttcher, B., Seeber, B., Leyendecker, G., & Wildt, L. (2017) · Fertility and Sterility · doi:10.1016/j.fertnstert.2017.06.009 · Cited by 115
Resistance to Diet-Induced Obesity in μ-Opioid Receptor–Deficient Mice
Tabarin, A., Diz-Chaves, Y., Carmona, M. C., Catargi, B., Zorrilla, E. P., Roberts, A. J., Coscina, D. V., Rousset, S., Redonnet, A., Parker, G. C., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.12.3510 · Cited by 113
Hedonic and motivational roles of opioids in food reward: Implications for overeating disorders
Peciña, S., & Smith, K. S. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.05.016 · Cited by 125
“While antagonists may be effective at reducing short-term appetitive behaviors (Yeomans and Gray, 2002), long-term compulsions may be harder to curb with antagonist treatment once ingrained in the individual (Atkinson, 1987; Fruzzetti et al., 2002).”
Metadata
- Authors
- Fruzzetti, F., Bersi, C., Parrini, D., Ricci, C., & Genazzani, A. R.
- Affiliations
- University of Pisa (IT)
- Corresponding author
- Fruzzetti, Franca
- Genazzani, Andrea Riccardo
- ORCID
- Fruzzetti, Franca
- Venue
- Fertility and Sterility
- Publisher
- Elsevier BV
- Published
- 2002-05
- Volume
- 77
- Issue
- 5
- Pages
- 936-944
- ISSN
- 0015-0282 (ISSN-L)
- OpenAlex
- W2046547866
- Cited by
- 62
- References
- 38
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 3 · 2023: 1 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 2 · 2016: 2 · 2015: 2 · 2013: 4 · 2012: 5
- FWCI
- 3.03
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 7439 d)
- Locations
- Fertility and Sterility (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Keywords
- naltrexone, polycystic ovary syndrome, obesity, insulin resistance, menstrual cyclicity, body mass index, gonadotropins, sex hormones, androstenedione, dehydroepiandrosterone sulfate, cortisol, thyroid hormones, GnRH stimulation, weight loss
- MeSH terms
- Adult, Androgens, Blood Glucose, Drug Administration Schedule, Endocrine Glands, Fasting, Female, Gonadotropins, Humans, Hydrocortisone, Insulin, Insulin Resistance, Menstrual Cycle, Naltrexone, Narcotic Antagonists, Obesity, Polycystic Ovary Syndrome, Time Factors, Body Mass Index
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. https://app.cochat.ai/papers/10.1016/s0015-0282(02)02955-2
- The paper
- Fruzzetti, F., Bersi, C., Parrini, D., Ricci, C., & Genazzani, A. R. (2002). Effect of long-term naltrexone treatment on endocrine profile, clinical features, and insulin sensitivity in obese women with polycystic ovary syndrome. Fertility and Sterility. https://doi.org/10.1016/s0015-0282(02)02955-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.